JPMorgan Chase & Co’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.8M Buy
3,094,598
+170,246
+6% +$1.92M ﹤0.01% 1405
2025
Q1
$27.7M Sell
2,924,352
-266,093
-8% -$2.52M ﹤0.01% 1487
2024
Q4
$35.9M Sell
3,190,445
-925,600
-22% -$10.4M ﹤0.01% 1344
2024
Q3
$116M Sell
4,116,045
-238,695
-5% -$6.75M 0.01% 821
2024
Q2
$83.3M Sell
4,354,740
-392,367
-8% -$7.5M 0.01% 911
2024
Q1
$156M Sell
4,747,107
-1,170,577
-20% -$38.4M 0.01% 692
2023
Q4
$195M Sell
5,917,684
-130,802
-2% -$4.32M 0.02% 575
2023
Q3
$165M Buy
6,048,486
+178,993
+3% +$4.87M 0.02% 567
2023
Q2
$178M Buy
5,869,493
+308,943
+6% +$9.36M 0.02% 578
2023
Q1
$180M Buy
5,560,550
+202,674
+4% +$6.58M 0.02% 533
2022
Q4
$150M Sell
5,357,876
-488,129
-8% -$13.7M 0.02% 569
2022
Q3
$210M Sell
5,846,005
-253,244
-4% -$9.1M 0.03% 444
2022
Q2
$187M Sell
6,099,249
-39,843
-0.6% -$1.22M 0.03% 498
2022
Q1
$198M Buy
6,139,092
+38,364
+0.6% +$1.24M 0.02% 538
2021
Q4
$169M Sell
6,100,728
-108,769
-2% -$3.01M 0.02% 595
2021
Q3
$192M Sell
6,209,497
-44,196
-0.7% -$1.37M 0.02% 552
2021
Q2
$132M Sell
6,253,693
-719,501
-10% -$15.2M 0.02% 726
2021
Q1
$141M Buy
6,973,194
+450,359
+7% +$9.1M 0.02% 659
2020
Q4
$105M Sell
6,522,835
-125,457
-2% -$2.01M 0.02% 706
2020
Q3
$85.5M Buy
6,648,292
+161,389
+2% +$2.08M 0.01% 697
2020
Q2
$46.2M Buy
6,486,903
+1,061
+0% +$7.56K 0.01% 862
2020
Q1
$35.2M Buy
6,485,842
+169,311
+3% +$919K 0.01% 877
2019
Q4
$57.2M Buy
6,316,531
+52,219
+0.8% +$473K 0.01% 812
2019
Q3
$45M Buy
6,264,312
+1,490,749
+31% +$10.7M 0.01% 914
2019
Q2
$37.6M Sell
4,773,563
-2,708,984
-36% -$21.3M 0.01% 1009
2019
Q1
$94.1M Buy
7,482,547
+366,226
+5% +$4.61M 0.02% 618
2018
Q4
$142M Sell
7,116,321
-78,173
-1% -$1.56M 0.03% 471
2018
Q3
$204M Buy
7,194,494
+217,930
+3% +$6.19M 0.04% 427
2018
Q2
$147M Sell
6,976,564
-414,661
-6% -$8.73M 0.03% 499
2018
Q1
$105M Sell
7,391,225
-78,849
-1% -$1.12M 0.02% 574
2017
Q4
$91.9M Buy
7,470,074
+5,055
+0.1% +$62.2K 0.02% 644
2017
Q3
$136M Buy
7,465,019
+2,026,893
+37% +$37M 0.03% 494
2017
Q2
$138M Buy
5,438,126
+379,185
+7% +$9.61M 0.03% 477
2017
Q1
$113M Buy
5,058,941
+2,790,791
+123% +$62.2M 0.03% 532
2016
Q4
$33.6M Buy
2,268,150
+125,350
+6% +$1.86M 0.01% 1015
2016
Q3
$52.8M Buy
2,142,800
+804,562
+60% +$19.8M 0.01% 736
2016
Q2
$25.7M Buy
1,338,238
+47,773
+4% +$917K 0.01% 1091
2016
Q1
$13.6M Buy
1,290,465
+361,945
+39% +$3.82M ﹤0.01% 1441
2015
Q4
$11.2M Buy
928,520
+12,586
+1% +$152K ﹤0.01% 1534
2015
Q3
$14.6M Buy
915,934
+11,032
+1% +$176K ﹤0.01% 1332
2015
Q2
$17.6M Buy
+904,902
New +$17.6M ﹤0.01% 1330